Cardiovascular Medicine
-
NON-WHITE ETHNICITY, MALE SEX, AND HIGHER BODY MASS INDEX, BUT NOT MEDICATIONS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ARE ASSOCIATED WITH CORONAVIRUS DISEASE 2019 (COVID-19) HOSPITALISATION: REVIEW OF THE FIRST 669 CASES FROM THE UK BIOBANK
This article has 8 authors:Reviewed by ScreenIT
-
Pre-existing Cardiovascular Disease in United States Population at High Risk for Severe COVID-19 Infection
This article has 1 author:Reviewed by ScreenIT
-
Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis
This article has 5 authors:Reviewed by ScreenIT
-
Impact of hospitalised patients with COVID-19 taking Renin-Angiotensin-Aldosterone System inhibitors: a systematic review and meta-analysis
This article has 3 authors:Reviewed by ScreenIT
-
Interventions Using Heart Age for Cardiovascular Disease Risk Communication: Systematic Review of Psychological, Behavioral, and Clinical Effects
This article has 7 authors:Reviewed by ScreenIT
-
The impact of a dedicated coronavirus disease 2019 primary angioplasty protocol on time components related to ST‑segment elevation myocardial infarction management in a 24/7 primary percutaneous coronary intervention–capable hospital
This article has 15 authors:Reviewed by ScreenIT
-
Elevated d-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019
This article has 9 authors:Reviewed by ScreenIT
-
COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system
This article has 16 authors:Reviewed by ScreenIT
-
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
This article has 18 authors:Reviewed by ScreenIT
-
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
This article has 14 authors:Reviewed by ScreenIT